Skip to main content

Published locations for Study results suggest ustekinumab may trigger acute CV events early in treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Study results suggest ustekinumab may trigger acute CV events early in treatment

User login

  • Reset your password
  • /content/study-results-suggest-ustekinumab-may-trigger-acute-cv-events-early-treatment
  • /edermatologynews/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger-acute-cv
  • /gihepnews/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger-acute-cv-events
  • /rheumatologynews/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger-acute-cv
  • /ecardiologynews/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger-acute-cv
  • /cardiology/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger-acute-cv-events
  • /rheumatology/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger-acute-cv-events
  • /dermatology/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger-acute-cv-events
  • /psoriatic-arthritis-icymi/article/228778/psoriasis/study-results-suggest-ustekinumab-may-trigger